| Organic NPs |
Liposomes, micelles, dendrimers, nanogels |
Biodegradable and biocompatible; surface easily functionalized; suitable for hydrophilic and hydrophobic drugs; controlled drug release |
Poor physical stability; prone to leakage or fusion; limited circulation time |
| Inorganic NPs |
Gold NPs, silica NPs, quantum dots, carbon nanotubes |
High structural stability; tunable optical/electronic properties; potential for imaging and theranostics |
Poor biodegradability, potential long-term toxicity, and accumulation in organs |
| Hybrid NPs |
Lipid–polymer hybrids, MOFs, polymer-coated metal NPs |
Combine the advantages of both organic and inorganic NPs; improved drug stability and targeting, and multifunctional capabilities |
Complex synthesis, scalability issues, cost and regulatory concerns |